mRNA-1769

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1769, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age [Phase 1, Phase 2]

See pricing